X0708 D LIVE 0001541157 Akari Therapeutics Plc 401 EAST JACKSON STREET SUITE 3300 TAMPA FL FLORIDA 33602 (929) 274-7510 UNITED KINGDOM None Celsus Therapeutics Plc. Morria Biopharmaceuticals PLC Other Public Limited Company true Abizer Gaslightwala Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Director President and Chief Executive Officer Kameel Farag Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Interim Chief Financial Officer Rob Bazemore Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Hoyoung Huh Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Jim Neal Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Ray Prudo Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Samir Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Sandip Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Other Health Care Decline to Disclose 06b false 2026-05-20 false true true true American Depositary Shares (ADSs), each representing 80,000 Ordinary Shares false 0 Paulson Investment Company, LLC 000005670 None None 150 2nd Avenue, North Suite 1550 St. Petersburg FL FLORIDA 33701 AZ ARIZONA FL FLORIDA false 5500000 1833333 3666667 Offering of ADSs, Pre-Funded Warrants, Series H, I and J Warrants, each convertible into one ADS for $5,500,000. Approximately $1,833,333 raised to date. The issuance of Series Warrants are subject to shareholder approval. false 6 125000 0 Paulson is also entitled to a fee equal to 2.0% of the gross proceeds, a non-accountable expense of $15,000, and 117,647 Placement Agent ADSs. The issuance of the Placement Agent ADSs are subject to receipt of shareholder approval. 0 The Company intends to use the net proceeds for working capital and general corporate purposes. false Akari Therapeutics Plc /s/ Abizer Gaslightwala Abizer Gaslightwala Chief Executive Officer and President 2026-06-03